Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02034123
Title Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

lung small cell carcinoma

Therapies

GSK2879552

Age Groups: adult
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
GSK Investigational Site Saint Louis Missouri 63110 United States Details
GSK Investigational Site Columbus Ohio 43210 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Villejuif cedex 94805 France Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Madrid 28034 Spain Details
GSK Investigational Site Madrid 28040 Spain Details
GSK Investigational Site Málaga 29010 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field